RDPTF — Radiopharm Theranostics Ltd

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1949257 · Australia
Last close
$0.01
Market Cap
$28.89M
52W High
$0.02
52W Low
$0.00
ADV30
0
Next earnings
—
No quarterly fundamentals indexed for this ticker.

Balance + Analyst (yfinance extras)

Retained Earnings
$-127,785,301
Inventory
—
Receivables
$6,250,693
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$13,502,270
EBITDA
$-49,613,928
Free Cash Flow
$-30,744,724
Enterprise Value
$17,117,056
Total Cash
$4,138,074
Total Debt
$0
Shares Out
4,337,549,491
Trailing EPS
$-0.01
Book Value
$0.01
ROE
-174.7%
ROA
-44.6%
Div Yield
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Jun 2026 2,767,888 -58,223,929 -56,950,494 60,133,579 37,809,896 24,687,209 —
Jun 2025 3,633,422 -34,640,735 -38,342,457 86,481,876 43,609,972 44,792,004 —
Jun 2024 299,228 -37,173,885 -47,949,119 72,036,345 44,683,059 28,122,562 —
Jun 2023 292,359 -31,690,601 -34,611,194 74,949,668 29,370,243 44,384,488 —
Jun 2022 — — — — — — —

Peers — same industry

TickerNameMarket CapLastDaily %
PMN ProMIS Neurosciences Inc. $28.88M $3.21 —
AYTU AYTU BIOPHARMA, INC $28.91M $2.66 —
SCYX SCYNEXIS INC $28.37M $2.85 —
PYRGF PyroGenesis Canada Inc. $28.34M $0.13 —
PRRUF IMMUTEP Ltd $29.47M $0.02 —

News headlines (Yahoo Finance, 1h cache)

Radiopharm Theranostics Presents Interim Analysis from Phase 2b Imaging Study of RAD101 in Suspected Recurrent Brain Metastases Following Radiotherapy at the Society for Neuro-Oncology Annual Meeting
2026-11-16 13:00 · Yahoo
UPDATE – International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 12, 2026
2026-11-09 16:56 · Yahoo
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 12, 2026
2026-11-05 13:35 · Yahoo
Radiopharm Theranostics Announces Alignment with U.S. FDA on Single Pivotal Phase 3 Trial for RAD101 in Diagnosis of Brain Metastases
2026-11-04 12:00 · Yahoo
Radiopharm Theranostics Reports Business Update
2026-11-02 13:00 · Yahoo
GE HealthCare Wins Approval for MINItrace Magni Cyclotron in Europe
2026-10-20 13:00 · Yahoo
Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101
2026-10-05 12:00 · Yahoo
Edison Issues Report on Starpharma (SPL)
2026-09-30 08:23 · Yahoo
Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of RAD101 at 2026 Society of Neuro-Oncology Annual Meeting
2026-09-14 12:00 · Yahoo
Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma
2026-09-09 11:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.